We evaluated the epidemiological features and main risk factors of Crimean-Congo haemorrhagic fever (CCHF) in Corum, where the disease is endemic, by retrospectively analysing the medical records of all patients diagnosed with CCHF over five years. Diagnosis was made by the detection of virus RNA via reverse transcription polymerase chain reaction or by demonstrating IgM antibody of CCHF virus with an ELISA blood test. Of 399 patients, 22 (5.5%) patients died but we could show that the rates of incidence and mortality have decreased over the years. Early referral to health facilities, increased awareness and experience of health personnel working in high-risk areas may well be the main factor.
Al-AbriSAl AbaidaniIFazlalipourM, et al.Current status of Crimean-Congo haemorrhagic fever in the World Health Organization Eastern Mediterranean Region: issues, challenges, and future directions. Int J Infect Dis2017; 58: 82–89.
2.
ShayanSBokaeanMShahrivarMR, et al.Crimean Congo Hemorrhagic Fever. Lab Medicine2015; 46: 180–189.
DreshajSAhmetiSRamadaniN, et al.Current situation of Crimean-Congo hemorrhagic fever in southeastern Europe and neighboring countries: a public health risk for the European Union?Travel Med Infect Dis2016; 14: 81–91.
5.
GalePEstrada-PenaAMartinezM, et al.The feasibility of developing a risk assessment for the impact of climate change on the emergence of Crimean-Congo haemorrhagic fever in livestock in Europe: a review. J App Microbiol2010; 108: 1859–1870.
6.
ElevliMOzkulAACivilibalM, et al.A newly identified Crimean-Congo hemorrhajic fever virus strain in Turkey. Int J Infect Dis2010; 14: 213–216.
7.
YılmazGRBuzganTIrmakH, et al.The epidemiology of Crimean-Congo hemorrhagic fever in Turkey, 2002–2007. Int J Infect Dis2009; 13: 380–386.
8.
BodurHAkıncıEAscıogluS, et al.Subclinical Infections with CrimeanCongo Hemorrhagic Fever Virus, Turkey. Emerg Infect Dis2012; 18: 640–642.
9.
SismanA. Epidemiologic Features and Risk Factors of Crimean-Congo Hemorragic Fever in Samsun Province, Turkey. J Epidemiol2013; 23: 95–102.
10.
ElaldıN. Epidemiology of Crimean-Congo Hemorrhagic Fever. C Ü Tıp Fak Derg2004; 26: 185–90.
11.
UyarYChristovaIPapaA. Currentsituation of Crimean-Congo hemorrhagic fever (CCHF) in Anatolia and Balkan Peninsula. Türk Hij Den Biyol Derg2011; 68: 139–151.
12.
GargiliAMidilliKErgonulO, et al.Crimean-Congo Hemorrhagic Fever in European Part of Turkey: Genetic Analysis of the Virüs Strains from Ticks and a Seroepidemiological Study in Humans. Vector-Borne Zoonotic Dis2011; 11: 747–752.
13.
KilincCGückanRCaprazM, et al.Examination of the specific clinical symptoms and laboratory findings of Crimean-Congo hemorrhagic fever. J Vector Borne Dis2016; 53: 162–167.
14.
HasanogluIGunerRCarhanA, et al.Crucial parameter of the outcome in Crimean-Congo hemorrhagic fever: Viral load. J Clin Virol2016; 75: 42–46.
15.
InceYYasaCMetinM, et al.Crimean-Congo hemorrhagic fever infections reported by ProMED. Int J Infect Dis2014; 26: 44–46.
16.
GünaydınNSAydınKYılmazG, et al.Crimean-Congo hemorrhagic fever cases in the eastern Black Sea Region of Turkey: demographic, geographic, climatic and clinical characteristics. Turk J Med Sci2010; 40: 829–834.
17.
AnsariHShahbazBIzadiS, et al.CrimeanCongo hemorrhagic fever and its relationship with climate factors in southeast Iran: a 13-year experience. J Infect Dev Ctries2014; 8: 749–757.
18.
PenaAEVatanseverZGargiliA, et al.An early warning system for Crimean Congo hemorrhagic fever seasonality in Turkey based on remote sensing technology. Geospatial Health2007; 2: 127–135.
